Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Hepatitis 17. August 2017
Erweiterte Suche
Abklärungen / Diagnostik
News / Journalscreening
Portale Hypertonie
Kongresse / Tagungen
Services / Tools
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 3051  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 61003  
Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.
Infect Genet Evol
Ellwanger JH, de Lima Kaminski V, Valverde-Villegas JM, Simon D, Lunge VR, Chies JAB.
PMID: 28811194 [PubMed - as supplied by publisher]

Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients.
Ann Hepatol
Candia R, Norero B, Agu Ero C, Díaz L, Ortega JP, Wolff R, Hernández-Rocha C, Duarte I, Soza A, Benítez C, Arrese M.
PMID: 28809732 [PubMed - in process]

Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial.
Ann Hepatol
Yoshida EM, Hussaini T.
PMID: 28809730 [PubMed - in process]

Prevalence of chronic hepatitis B and C in psoriasis patients: A cross-sectional study in a large US population.
J Am Acad Dermatol
Orrell KA, Vakharia PP, Hagstrom EL, Brieva J, West DP, Nardone B.
PMID: 28807111 [PubMed - in process]

Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response.
Chan ST, Ou JJ.
PMID: 28805674 [PubMed - in process]

Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study.
World J Hepatol
Montasser MF, Abdelkader NA, Abdelhakam SM, Dabbous H, Montasser IF, Massoud YM, Abdelmoaty W, Saleh SA, Bahaa M, Said H, El-Meteini M.
PMID: 28804572 [PubMed]

A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
Cao YF, Tao H, Hu YM, Shi CB, Wu X, Liang Q, Chi CP, Li L, Liang ZL, Meng JH, Zhu FC, Liu ZH, Wang XP.
PMID: 28803715 [PubMed - as supplied by publisher]

Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial.
Expert Rev Vaccines
Feng Y, Shi X, Shi J, Gao L, Liu G, Cheng Y, Pan M, Li C, Wang J, Guo X, Zhang Y, Liang X, Wang S.
PMID: 28803502 [PubMed - as supplied by publisher]

Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
Gane EJ, Pianko S, Roberts SK, Thompson AJ, Zeuzem S, Zuckerman E, Ben-Ari Z, Foster GR, Agarwal K, Laursen AL, Gerstoft J, Gao W, Huang HC, Fitzgerald B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Zeng Z, Chen HL, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Esteban R.
PMID: 28802816 [PubMed - as supplied by publisher]

Shortening the duration of therapy for chronic hepatitis C infection.
Lancet Gastroenterol Hepatol
Emmanuel B, Wilson EM, O'Brien TR, Kottilil S, Lau G.
PMID: 28802815 [PubMed - as supplied by publisher]

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
Lawitz E, Buti M, Vierling JM, Almasio PL, Bruno S, Ruane PJ, Hassanein TI, Muellhaupt B, Pearlman B, Jancoriene L, Gao W, Huang HC, Shepherd A, Tannenbaum B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Yoshida EM.
PMID: 28802814 [PubMed - as supplied by publisher]

Detecting Exact Breakpoints of Deletions with Diversity in Hepatitis B Viral Genomic DNA from Next-Generation Sequencing Data.
Cheng JH, Liu WC, Chang TT, Hsieh SY, Tseng VS.
PMID: 28802713 [PubMed - as supplied by publisher]

Impact of hepatitis B vaccination on HBsAg kinetics, interferon-inducible protein 10 level and recurrence of viremia.
Shaaban Hanafy A.
PMID: 28802168 [PubMed - as supplied by publisher]

Prevalence of hepatitis C virus infection and its correlates in a rural area of southwestern China: a community-based cross-sectional study.
BMJ Open
Cheng W, Yang Y, Zhou Y, Xiao P, Shi Y, Gao J, Chen Y, Liang S, Yihuo W, Song X, Jiang Q.
PMID: 28801405 [PubMed - in process]

Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection.
Liu Y, Li ZY, Li X, Wang JN, Huang QA, Huang Y.
PMID: 28800545 [PubMed - as supplied by publisher]

The Italian Compassionate use of Sofosbuvir (ITACOPS) observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.
Transpl Int
Carrai P, Morelli C, Cordone G, Romano A, Tamé M, Lionetti R, Pietrosi G, Lenci I, Piai G, Russo FP, Coppola C, Melazzini M, Montilla S, Pani L, Petraglia S, Russo P, Trotta MP, Martini S, Toniutto P, ITACOPS study group..
PMID: 28799277 [PubMed - as supplied by publisher]

Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.
Clin Ther
Chen J, Zhao SS, Liu XX, Huang ZB, Huang Y.
PMID: 28797777 [PubMed - as supplied by publisher]

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review.
Int J Drug Policy
Bajis S, Dore GJ, Hajarizadeh B, Cunningham EB, Maher L, Grebely J.
PMID: 28797498 [PubMed - as supplied by publisher]

Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.
Euro Surveill
Garvey P, O'Grady B, Franzoni G, Bolger M, Irwin Crosby K, Connell J, Burke D, De Gascun C, Thornton L.
PMID: 28797323 [PubMed - in process]

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
PLoS One
Huang CM, Chang KC, Hung CH, Chiu KW, Lu SN, Wang JH, Chen CH, Kee KM, Kuo YH, Tsai MC, Tseng PL, Lin MT, Wu CK, Hu TH, Cho CL, Yen YH.
PMID: 28797039 [PubMed - in process]

   Artikel 1 - 20 / 61003    Seite 1 von 3051  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer



Das Fachportal für Eisenmangel >>


Sky right 1